Featured Research

from universities, journals, and other organizations

Researchers Identify Protein That Regulates Killer Cells

Date:
June 21, 2002
Source:
University Of Toronto
Summary:
Researchers at the University of Toronto and Mount Sinai Hospital have identified a protein that plays a critical role in the regulation of "natural killers cells" in the immune system's battle against foreign and diseased cells.

Researchers at the University of Toronto and Mount Sinai Hospital have identified a protein that plays a critical role in the regulation of "natural killers cells" in the immune system's battle against foreign and diseased cells.

"Our research is a small part of the larger problem of how viruses and diseased cells ravage the body and circumvent our immune system," says Kathleen Binns, a U of T doctoral student in medical genetics and microbiology and an author on a paper in the June 20 issue of Science.

Using mass spectrometry, Binns, who does research in the Samuel Lunenfeld Research Institute at Mount Sinai and MDS Sciex, sequenced and identified a mystery protein from co-researchers at the Swiss Federal Institute of Technology in Switzerland.

Once identified, the protein (SSPase) was sent back to the Swiss researchers where they cloned its gene and sequenced its DNA. That gene, they discovered, is a key component involved in regulation of "natural killer cells" - cells produced by the body's immune system that attack foreign or mutated cells like caused by viruses or cancer.

"This research gives us a better understanding of how the immune system works. As a result, we have a better understanding of how viruses and cancer try to get around this process. One day, we will hopefully be able to develop treatments and therapies to counter these rogue cells," says Binns.

A group of genes called the major histocompatibility complex I (MHC-I) are a natural part of the immune system and present in most cells in the body, explains Binns. Acting like an information relay, the MHC-I molecules retrieve bits and pieces of the proteins from inside the cell and display them on the cell surface. "MHC complexes essentially give a read out of what's inside the cell," she says.

T-cells, one of the main components of the immune system, "examine" the protein fragments on the cell surface and if they recognize them, the T-cells move on. If, however, the T-cells do not recognize the fragments, the cell may be hosting a virus or manufacturing mutant proteins (as in the case of cancer). The T-cells then react by attacking and killing the "diseased" cells.

Some virus and tumor cells, however, have evolved mechanisms that circumvent the T-cell attack by stopping MHC production and the display of disease proteins, says Binns.

As a countermeasure, the researchers found that the immune system developed a monitor that employs the SSPase protein and uses a second type of immune cell known as a natural killer cell, she notes. The protein processes MHC-I molecules to make a peptide signal. If sufficient levels of the MHC-I protein are present in the cell, the natural killer cell moves on. If, however, the killer cell detects insufficient levels of the MHC-I protein because it has not received the particular peptide signal, the killer cell attacks and destroys the suspect cell.

"This process is a check on viruses and abnormal cells that try to bypass the T-cell system," says Binns. "Viruses become smarter, our immune systems work to counteract them and the viruses get smarter again. There's this constant evolution for the drive to survive, and viruses and cancer cells have the same drive to survive that we do."

Binns conducted the research with Andreas Weihofen, lead author on the study, Marius Lemberg and Bruno Martoglio of the Institute of Biochemistry at the Swiss Federal Institute of Technology, and Keith Ashman, an investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital.

This research was funded by the Natural Science and Engineering Research Council of Canada and MDS Sciex, the Swiss Federal Institute of Technology and the Swiss National Science Foundation.


Story Source:

The above story is based on materials provided by University Of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University Of Toronto. "Researchers Identify Protein That Regulates Killer Cells." ScienceDaily. ScienceDaily, 21 June 2002. <www.sciencedaily.com/releases/2002/06/020621080829.htm>.
University Of Toronto. (2002, June 21). Researchers Identify Protein That Regulates Killer Cells. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/06/020621080829.htm
University Of Toronto. "Researchers Identify Protein That Regulates Killer Cells." ScienceDaily. www.sciencedaily.com/releases/2002/06/020621080829.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins